| Cat. No. |
Product Name |
Information |
| PC-20087 |
TAK-385
GnRH receptor inhibitor
|
TAK-385 (Relugolix, TAK385) is a potent, orally active, non-peptide antagonist of human gonadotropin-releasing hormone (GnRH) receptor, inhibits GnRH-stimulated AA release from CHO cells expressing human GnRH receptor with IC50 of 0.85 nM. |
| PC-20045 |
Merigolix
GnRH receptor inhibitor
|
Merigolix is a potent, selective gonadotrophin releasing hormone (GnRH) antagonist. |
| PC-38730 |
BAY1214784
GnRH-R antagonist
|
BAY 1214784 (BAY-784) is an orally available, potent, and selective antagonist of gonadotropin-releasing hormone receptor (GnRH-R) with IC50 of 21/ 24/ 35 nM for human/rat/cynomolgus GnRH-R, respectively. |
| PC-38090 |
GnRH antagonist 2
GnRH antagonist
|
GnRH antagonist 2 is a GnRH receptor antagonist that can be used for endometriosis research.. |
| PC-43103 |
Leuprorelin
GnRH agonist
|
Leuprorelin (Leuprolide) is a GnRH analog and agonist of GnRH receptor, interrupts the normal pulsatile stimulation and desensitizing of the GnRH receptors. |
| PC-61391 |
Opigolix
GnRH antagonist
|
Opigolix (ASP-1707, ASP1707) is a potent gonadotrophin releasing hormone (GnRH) antagonist, significantly reduces endometriosis-associated pelvic pain. |
| PC-61385 |
Linzagolix
GnRH antagonist
|
Linzagolix (KLH-2109, OBE-2109) is a potent, non-peptide, and orally active gonadotrophin releasing hormone (GnRH) antagonist, inhibits GnRH-stimulated Ca2+ flux with IC50 of 36.7 nM (human GnRH receptor). |
| PC-23478 |
Ozarelix
GnRH antagonist
|
Ozarelix (D-63153) is a fourth generation GnRH antagonist, shows antiproliferative effects and produces an accumulation of cells in G2/M cell cycle phase. |
| PC-23477 |
Ganirelix acetate
GnRH antagonist
|
Ganirelix acetate (Ganirest) is an injectable competitive gonadotropin-releasing hormone (GnRH) antagonist, directly competes against the endogenous molecule for receptor binding, and causes a rapid reduction in estradiol levels. |
| PC-23476 |
Elagolix sodium
GnRH antagonist
|
Elagolix (NBI-56418) sodium is a highly effective, selective, orally bioavailable, non-peptide gonadotropin-releasing hormone receptor (GnRH) antagonist with KD value of 54 pM. |
| PC-23475 |
Elagolix
GnRH antagonist
|
Elagolix (NBI-56418) is a highly effective, selective, orally bioavailable, non-peptide gonadotropin-releasing hormone receptor (GnRH) antagonist with KD value of 54 pM. |
| PC-23474 |
Cetrorelix acetate
GnRH antagonist
|
Cetrorelix acetate (SB-75 acetate) is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with IC50 of 1.21 nM. |
